PEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-HSD1

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Zhou, Yinli ^a   Xu, Fen ^a   Deng, Hongrong ^a   Bi, Yan ^a   Sun, Weiping ^a   Zhao, Yi ^a   Chen, Zonglan ^a   Weng, Jianping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; ADIPONECTIN; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; PIGMENT EPITHELIUM DERIVED FACTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; TRANSCRIPTION INITIATION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; DEXAMETHASONE; DIABETES MELLITUS, TYPE 2; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MIDDLE AGED; NERVE GROWTH FACTORS; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SERPINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893176187     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084016     Document Type: Article

References (35)

1. Tombran-Tink J, Chader GG, Johnson LV (1991) PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 53: 411-414. doi:10.1016/0014-4835(91)90248-D. PubMed: 1936177.
2. Tombran-Tink J, Johnson LV (1989) Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci 30: 1700-1707. PubMed: 2668219. (Pubitemid 19214990)
3. Yamagishi S, Matsui T, Nakamura K, Ueda S, Noda Y et al. (2008) Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications. Curr Drug Targets 9: 1025-1029. doi:10.2174/138945008786786154. PubMed: 18991613.
4. Abe R, Fujita Y, Yamagishi S (2007) Angiogenesis and metastasis inhibitors for the treatment of malignant melanoma. Mini Rev Med Chem 7: 649-661. doi:10.2174/138955707780859440. PubMed: 17584162. (Pubitemid 47099184)
5. Matsuoka M, Ogata N, Minamino K, Matsumura M (2007) Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy. Mol Vis 13: 1058-1065. PubMed: 17653050. (Pubitemid 47034649)
6. Yamagishi SI, Matsui T (2010) Anti-atherothrombogenic properties of PEDF. Curr Mol Med 10: 284-291. doi:10.2174/156652410791065264. PubMed: 20236055.
7. Park K, Jin J, Hu Y, Zhou K, Ma JX (2011) Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization. Am J Pathol 178: 688-698. doi:10.1016/j.ajpath.2010.10.014. PubMed: 21281801.
8. Choi KM, Hwang SY, Hong HC, Yang SJ, Choi HY et al. (2012) C1q/TNF-Related Protein-3 (CTRP-3) and Pigment Epithelium-Derived Factor (PEDF) Concentrations in Patients With Type 2 Diabetes and Metabolic Syndrome. Diabetes, 61: 2932-6. PubMed: 22837306.
9. Borg ML, Andrews ZB, Duh EJ, Zechner R, Meikle PJ et al. (2011) Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes 60: 1458-1466. doi:10.2337/db10-0845. PubMed: 21464445.
10. Crowe S, Wu LE, Economou C, Turpin SM, Matzaris M et al. (2009) Pigment epithelium-derived factor contributes to insulin resistance in obesity. Cell Metab 10: 40-47. doi:10.1016/j.cmet.2009.06.001. PubMed: 19583952.
11. Jenkins A, Zhang SX, Gosmanova A, Aston C, Dashti A et al. (2008) Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. Diabetes Res Clin Pract 82: e5-e7. doi:10.1016/j.diabres.2008.06.019. PubMed: 18715664.
12. Nakamura K, Yamagishi S, Adachi H, Kurita-Nakamura Y, Matsui T et al. (2009) Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes. Diabetes Metab Res Rev 25: 52-56. doi:10.1002/dmrr.820. PubMed: 18677713.
13. Yamagishi S, Adachi H, Abe A, Yashiro T, Enomoto M et al. (2006) Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab 91: 2447-2450. doi:10.1210/jc.2005-2654. PubMed: 16522692. (Pubitemid 43855041)
14. Ogata N, Matsuoka M, Matsuyama K, Shima C, Tajika A et al. (2007) Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy. J Clin Endocrinol Metab 92: 1176-1179. PubMed: 17213275. (Pubitemid 46465700)
15. Wang M, Wang JJ, Li J, Park K, Qian X et al. (2009) Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes. Am J Physiol Endocrinol Metab 297: E1378-E1387. doi:10.1152/ajpendo.00252.2009. PubMed: 19808909.
16. Perruccio EM, Rowlette LL, Comes N, Locatelli-Hoops S, Notari L et al. (2008) Dexamethasone increases pigment epithelium-derived factor in perfused human eyes. Curr Eye Res 33: 507-515. doi:10.1080/02713680802110208. PubMed: 18568889. (Pubitemid 351998845)
17. Weng J, Li Y, Xu W, Shi L, Zhang Q et al. (2008) Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 371: 1753-1760. doi:10.1016/S0140-6736(08)60762-X. PubMed: 18502299. (Pubitemid 351697950)
18. Bi Y, Sun WP, Chen X, Li M, Liang H et al. (2008) Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats. Acta Diabetol 45: 167-178. doi:10.1007/s00592-008-0038-7. PubMed: 18500427.
19. Tang T, Zhang J, Yin J, Staszkiewicz J, Gawronska-Kozak B et al. (2010) Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure. J Biol Chem 285: 4637-4644. doi:10.1074/jbc.M109.068007. PubMed: 20018865.
20. Gao Z, He Q, Peng B, Chiao PJ, Ye J (2006) Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function. J Biol Chem 281: 4540-4547. doi:10.1074/jbc.M507784200. PubMed: 16371367. (Pubitemid 43847886)
21. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D et al. (1997) 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A 94: 14924-14929. doi:10.1073/pnas.94.26.14924. PubMed: 9405715. (Pubitemid 28041476)
22. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ et al. (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294: 2166-2170. doi:10.1126/science.1066285. PubMed: 11739957. (Pubitemid 33150673)
23. Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC et al. (2004) Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A 101: 7088-7093. doi:10.1073/pnas.0305524101. PubMed: 15118095. (Pubitemid 38596447)
24. Spranger J, Osterhoff M, Reimann M, Möhlig M, Ristow M et al. (2001) Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes 50: 2641-2645. doi:10.2337/diabetes.50.12.2641. PubMed: 11723044. (Pubitemid 33733112)
25. Jenkins AJ, Zhang SX, Rowley KG, Karschimkus CS, Nelson CL et al. (2007) Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes. Diabet Med 24: 1345-1351. doi:10.1111/j.1464-5491.2007.02281.x. PubMed: 17971181. (Pubitemid 350179436)
26. Matsuoka M, Ogata N, Minamino K, Higuchi A, Matsumura M (2006) High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes. Exp Eye Res 82: 172-178. doi:10.1016/j.exer.2005.05.011. PubMed: 16054135. (Pubitemid 43063408)
27. Sunderland KL, Tryggestad JB, Wang JJ, Teague AM, Pratt LV et al. (2012) Pigment epithelium-Derived Factor (PEDF) Varies with Body Composition and Insulin Resistance in Healthy Young People. J Clin Endocrinol Metab 97: E2114-8. PubMed: 22930782.
28. Sabater M, Moreno-Navarrete JM, Ortega FJ, Pardo G, Salvador J et al. (2010) Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. J Clin Endocrinol Metab 95: 4720-4728. doi:10.1210/jc.2010-0630. PubMed: 20631025.
29. Böhm A, Ordelheide AM, Machann J, Heni M, Ketterer C et al. (2012) Common genetic variation in the SERPINF1 locus determines overall adiposity, obesity-related insulin resistance, and circulating leptin levels. PLOS ONE 7: e34035. doi:10.1371/journal.pone.0034035. PubMed: 22457810.
30. Chavan S, Hudson L, Li J, Ochani M, Harris Y et al. (2012) Identification of Pigment Epithelium-Derived Factor as an adipocyte derived inflammatory factor. Mol Med.
31. Gao G, Li Y, Zhang D, Gee S, Crosson C et al. (2001) Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett 489: 270-276. doi:10.1016/S0014-5793(01)02110-X. PubMed: 11165263. (Pubitemid 32126422)
32. Elayappan B, Ravinarayannan H, Pasha SP, Lee KJ, Gurunathan S (2009) PEDF inhibits VEGF- and EPO- induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation. Angiogenesis 12: 313-324. doi:10.1007/s10456-009-9153-5. PubMed: 19657716.
33. Lee JH, Gao Z, Ye J (2013) Regulation of 11beta-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-kappaB and HIF-1alpha. Am J Physiol Endocrinol Metab 304: E1035-E1041. doi:10.1152/ajpendo.00029.2013. PubMed: 23512810.
34. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E (2002) Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 277: 27975-27981. doi:10.1074/jbc.M204152200. PubMed: 12032158. (Pubitemid 34966746)
35. Morton NM, Seckl JR (2008) 11beta-hydroxysteroid dehydrogenase type 1 and obesity. Front Horm Res 36: 146-164. PubMed: 18230901.